【 #肺がん 】後編：進行・再発肺がんの治療とは？専門医が解説！

Lecturer: Dr. Yuuki Sato (Respiratory Medicine, Kobe City Medical Center General Hospital) Date: Friday, December 12, 2025 Topic: Lung Cancer (Part 2) - Advanced and Recurrent Lung Cancer We held a two-part lecture on lung cancer in 2025. Part 2 will focus on treatments for advanced and recurrent lung cancer. Part 1 is available here:    • 【 #肺がん 】前編：早期肺がんについて専門医が解説！   Additional Information on Immunotherapy: In the explanations on the slides below, the terms IO (Immuno-Oncology) and ICI (Immune Checkpoint Inhibitor) appear, both of which refer to immunotherapy. TTFields in Second-Line Treatment Tarlatamab in Small Cell Carcinoma Reference: https://ganjoho.jp/public/dia_tre/tre... Oncolo is recruiting subjects for clinical trials and conducting various research projects in which we request patient cooperation. Please take a look. List of Clinical Trials: https://oncolo.jp/ct Research Call: https://oncolo.jp/research ■ONCOLO Meets Cancer Experts (OMCE) https://oncolo.jp/feature/omce2025 ■Cancer Information Site "Oncolo" https://oncolo.jp/ ■ONCOLO X   / oncolo_ms   ■ONCOLO LINE https://lin.ee/p86ydC0 ■About ONCOLO Meets Cancer Experts (OMCE) "Should cancer treatment be left untreated?" "Do anti-cancer drugs work?" "Are clinical trials human experiments?" There's a mixed bag of cancer information. ONCOLO Meets Cancer Experts (OMCE), hosted by the cancer information site "Oncolo," is the ultimate cancer information seminar featuring cancer medical experts. ■OMCE Organizer Information Organizer Oncoro Cancer Information Site Sponsor West Japan Oncology Group (WJOG) Kinki Cancer Care Promotion Network A2 Healthcare Corporation Kobe Biomedical Innovation Center BGM: DOVA-SYNDROME https://dova-s.jp/